Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity

The coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2, has recently emerged worldwide. In this context, there is an urgent need to identify safe and effective therapeutic strategies for treatment of such highly contagious disease. We recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Hache, Guillaume, Rolain, Jean Marc, Gautret, Philippe, Deharo, Jean-Claude, Brouqui, Philippe, Raoult, Didier, Honoré, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Opinion Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987362/
https://www.ncbi.nlm.nih.gov/pubmed/33729874
http://dx.doi.org/10.1089/mdr.2020.0232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987362/
https://www.ncbi.nlm.nih.gov/pubmed/33729874
http://dx.doi.org/10.1089/mdr.2020.0232

Ejemplares similares